102 On the flip side, a number of teams are advocating for the incorporation of novel markers, such as a complex karyotype55 or epigenetic subsets, 27,28 into medical practice. Every one of these novel prognostic and/or predictive products will must be validated in cohorts of sufferers treated with focused agents. https://salvadorp482qwb5.shivawiki.com/user